Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.76 - $1.16 $6,232 - $9,512
-8,200 Reduced 36.93%
14,006 $11,000
Q2 2023

Aug 11, 2023

SELL
$0.92 - $1.4 $18,180 - $27,665
-19,761 Reduced 47.09%
22,206 $24,000
Q1 2023

May 12, 2023

SELL
$0.94 - $2.02 $30,550 - $65,650
-32,500 Reduced 43.64%
41,967 $41,000
Q4 2022

Feb 13, 2023

SELL
$1.01 - $53.8 $909 - $48,420
-900 Reduced 1.19%
74,467 $83,000
Q3 2022

Nov 14, 2022

SELL
$2.18 - $43.4 $872 - $17,360
-400 Reduced 0.53%
75,367 $161,000
Q2 2022

Aug 12, 2022

BUY
$2.65 - $4.12 $40,810 - $63,448
15,400 Added 25.51%
75,767 $221,000
Q1 2022

May 13, 2022

SELL
$2.65 - $4.84 $5,035 - $9,196
-1,900 Reduced 3.05%
60,367 $242,000
Q4 2021

Feb 11, 2022

SELL
$4.32 - $6.27 $122,688 - $178,068
-28,400 Reduced 31.32%
62,267 $284,000
Q3 2021

Nov 12, 2021

SELL
$5.23 - $8.89 $7,845 - $13,335
-1,500 Reduced 1.63%
90,667 $506,000
Q2 2021

Aug 13, 2021

SELL
$7.12 - $9.15 $47,412 - $60,929
-6,659 Reduced 6.74%
92,167 $677,000
Q1 2021

May 13, 2021

BUY
$6.81 - $9.64 $48,296 - $68,366
7,092 Added 7.73%
98,826 $734,000
Q4 2020

Feb 10, 2021

SELL
$6.13 - $9.08 $18,390 - $27,240
-3,000 Reduced 3.17%
91,734 $666,000
Q3 2020

Nov 13, 2020

BUY
$6.35 - $9.8 $79,375 - $122,500
12,500 Added 15.2%
94,734 $793,000
Q2 2020

Aug 13, 2020

BUY
$4.72 - $9.7 $59,325 - $121,919
12,569 Added 18.04%
82,234 $586,000
Q1 2020

May 14, 2020

BUY
$3.71 - $6.05 $40,646 - $66,283
10,956 Added 18.66%
69,665 $341,000
Q4 2019

Feb 13, 2020

BUY
$3.94 - $6.45 $48,205 - $78,915
12,235 Added 26.33%
58,709 $256,000
Q3 2019

Nov 13, 2019

BUY
$5.01 - $7.8 $36,993 - $57,595
7,384 Added 18.89%
46,474 $268,000
Q2 2019

Aug 12, 2019

BUY
$6.39 - $8.91 $249,785 - $348,291
39,090 New
39,090 $310,000

Others Institutions Holding SNOA

# of Institutions
1
Shares Held
2.27K
Call Options Held
0
Put Options Held
0

About Sonoma Pharmaceuticals, Inc.


  • Ticker SNOA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,100,940
  • Market Cap $8M
  • Description
  • Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...
More about SNOA
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.